These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15969255

  • 1. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.
    Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M.
    Hypertens Res; 2005 Jan; 28(1):51-7. PubMed ID: 15969255
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome in overweight and obese Japanese children.
    Yoshinaga M, Tanaka S, Shimago A, Sameshima K, Nishi J, Nomura Y, Kawano Y, Hashiguchi J, Ichiki T, Shimizu S.
    Obes Res; 2005 Jul; 13(7):1135-40. PubMed ID: 16076981
    [Abstract] [Full Text] [Related]

  • 3. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children.
    Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A, Taniyama M.
    Obes Res; 2003 Sep; 11(9):1072-9. PubMed ID: 12972677
    [Abstract] [Full Text] [Related]

  • 4. Lower birth weight and visceral fat accumulation are related to hyperinsulinemia and insulin resistance in obese Japanese children.
    Tanaka Y, Kikuchi T, Nagasaki K, Hiura M, Ogawa Y, Uchiyama M.
    Hypertens Res; 2005 Jun; 28(6):529-36. PubMed ID: 16231759
    [Abstract] [Full Text] [Related]

  • 5. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

  • 6. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.
    Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S.
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133
    [Abstract] [Full Text] [Related]

  • 7. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers.
    Lee S, Bacha F, Gungor N, Arslanian S.
    J Pediatr; 2008 Feb; 152(2):177-84. PubMed ID: 18206686
    [Abstract] [Full Text] [Related]

  • 8. Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome.
    Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I.
    Scand J Clin Lab Invest; 2005 Feb; 65(4):283-90. PubMed ID: 16076683
    [Abstract] [Full Text] [Related]

  • 9. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [Abstract] [Full Text] [Related]

  • 10. Serum adiponectin concentration and cardiovascular risk factors in climacteric women.
    Milewicz A, Zatonska K, Demissie M, Jêdrzejuk D, Dunajska K, Ilow R, Lwow F.
    Gynecol Endocrinol; 2005 Feb; 20(2):68-73. PubMed ID: 15823824
    [Abstract] [Full Text] [Related]

  • 11. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y, Hirose H, Saito I, Itoh H.
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [Abstract] [Full Text] [Related]

  • 12. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women.
    Kwon K, Jung SH, Choi C, Park SH.
    Int J Cardiol; 2005 Jun 08; 101(3):385-90. PubMed ID: 15907405
    [Abstract] [Full Text] [Related]

  • 13. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, Vanninen E, Laakso M.
    Circulation; 2004 Dec 21; 110(25):3842-8. PubMed ID: 15596567
    [Abstract] [Full Text] [Related]

  • 14. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J, McQuillan BM, Thompson PL, Beilby JP.
    Int J Obes (Lond); 2008 May 21; 32(5):772-9. PubMed ID: 18253163
    [Abstract] [Full Text] [Related]

  • 15. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
    Tajtákova M, Petrásova D, Petrovicová J, Pytliak M, Semanová Z.
    Endocr Regul; 2006 Mar 21; 40(1):15-9. PubMed ID: 16964963
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan 21; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 17. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
    Di Bonito P, Sanguigno E, Di Fraia T, Forziato C, Boccia G, Saitta F, Iardino MR, Capaldo B.
    Metabolism; 2009 Mar 21; 58(3):368-72. PubMed ID: 19217453
    [Abstract] [Full Text] [Related]

  • 18. Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
    Calcaterra V, Muratori T, Klersy C, Albertini R, Caramagna C, Brizzi V, Larizza D.
    Ann Nutr Metab; 2011 Oct 21; 58(4):307-14. PubMed ID: 21912108
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.
    Metab Syndr Relat Disord; 2009 Oct 21; 7(5):427-34. PubMed ID: 19754305
    [Abstract] [Full Text] [Related]

  • 20. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ, Harrell JS, Davenport ML.
    J Am Acad Nurse Pract; 2005 Dec 21; 17(12):535-41. PubMed ID: 16293162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.